Efficacy and Safety of Cyclophosphamide Treatment in Severe Juvenile Dermatomyositis Shown by Marginal Structural Modeling-Reference-Cited by-同舟云学术

Efficacy and Safety of Cyclophosphamide Treatment in Severe Juvenile Dermatomyositis Shown by Marginal Structural Modeling

Published:2018-03-25 Issue:5 Volume:70 Page:785-793
ISSN:2326-5191
Container-title:Arthritis & Rheumatology
language:en
Short-container-title:Arthritis Rheumatol

Author:

Deakin Claire T.¹,Campanilho-Marques Raquel¹²,Simou Stefania¹,Moraitis Elena¹,Wedderburn Lucy R.³,Pullenayegum Eleanor⁴,Pilkington Clarissa A.⁵,

Affiliation:

1. University College London Great Ormond Street Institute of Child Health; London UK

2. Hospital de Santa Maria; Centro Hospitalar Lisboa Norte; Lisbon Academic Medical Centre and Instituto Português de Reumatologia; Lisbon Portugal

3. University College London Great Ormond Street Institute of Child Health; Great Ormond Street Hospital for Children; NIHR Biomedical Research Centre at Great Ormond Street Hospital for Children; NHS Foundation Trust; and Arthritis Research UK Centre for Adolescent Rheumatology at University College London; University College London Hospital; and Great Ormond Street Hospital; London UK

4. Hospital for Sick Children; Toronto Ontario Canada

5. Great Ormond Street Hospital for Children; London UK

Funder

National Institute on Handicapped Research

Great Ormond Street Hospital for Children

NHS Foundation Trust

Institute of Child Health

University College London

NIHR Comprehensive Research Network

Arthritis Research UK

Myositis Association

Wellcome Trust